Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Lentiginosine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004200 AN006985 untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS Blood Mouse Environmental exposure University of Washington LC-MS
ST004200 AN006986 untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS Blood Mouse Environmental exposure University of Washington LC-MS
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST003362 AN005504 Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Cultured cells Human Cancer Ohio State University LC-MS
ST003362 AN005506 Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Cultured cells Human Cancer Ohio State University LC-MS
ST003333 AN005460 Urine Metabolite Profiling in Indian Male Population at High Altitude using Liquid Chromatography – Mass Spectrometry: A Longitudinal Pilot Study Urine Human Environmental exposure Defence Institute of Physiology and Allied Sciences LC-MS
ST003333 AN005460 Urine Metabolite Profiling in Indian Male Population at High Altitude using Liquid Chromatography – Mass Spectrometry: A Longitudinal Pilot Study Urine Human Hypoxia Defence Institute of Physiology and Allied Sciences LC-MS
ST003089 AN005052 Metabolome changes in embryonic CSF (Part 11) Cerebrospinal fluid Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Blood Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Cerebrospinal fluid Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Liver Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003087 AN005048 Metabolome changes in embryonic CSF (Part 9) Cerebrospinal fluid Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003086 AN005046 Metabolome changes in embryonic CSF (Part 8) Cerebrospinal fluid Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003085 AN005044 Metabolome changes in embryonic CSF (Part 7) Cerebrospinal fluid Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003084 AN005042 Metabolic changes in embryonic CSF (Part 6) Cerebrospinal fluid Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST002761 AN004487 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin LC-MS
ST002761 AN004489 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin LC-MS
ST002760 AN004483 Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) Kidney Rat Medical College of Wisconsin LC-MS
ST002760 AN004485 Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) Kidney Rat Medical College of Wisconsin LC-MS
ST002759 AN004479 Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) Kidney Rat Medical College of Wisconsin LC-MS
ST002759 AN004481 Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) Kidney Rat Medical College of Wisconsin LC-MS
ST002698 AN004372 Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites Infected Red Blood Cells Plasmodium berghei Malaria Peter Doherty Institute for Infection and Immunity LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST001658 AN002708 Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites Yeast cells Saccharomyces cerevisiae Cancer Johns Hopkins University LC-MS
ST000549 AN000837 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic LC-MS
  logo